In accordance with previous evidence that those with HER2-positive gastric cancer tumors have a higher percentage of developing brain metastases, our analysis found that HER2 status appears to be associated with a higher risk of having cerebral metastases [35,50]. This evidence concerns the gene ERBB2 and gastric cancer.